Inventor · disambiguated record
Akihito Nonoyama
Also filed as: NONOYAMA AKIHITO
4 granted patents·3 pending applications·1 citations·filing 2016–2022
59Inventor score
Files withSUMITOMO DAINIPPON PHARMA CO LTD2SUMITOMO DAINIPPON PHARMA ONCOLOGY INC2SUMITOMO PHARMA ONCOLOGY INC2MICROBIAL CHEM RES FOUND1
Top patents by PatentIndex Score
7 records- 0180US11013741B1AXL kinase inhibitors and use of the sameSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2019·Granted May 25, 2021·1 cites·11 claims
- 0268US2023165857A1Axl kinase inhibitors and use of the sameSUMITOMO PHARMA ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 0362US11400091B2AXL kinase inhibitors and use of the sameSUMITOMO PHARMA ONCOLOGY INC·Filed 2020·Granted Aug 2, 2022·0 cites·36 claims
- 0458US10413892B2Catalyst, production method therefor, and method for producing optically active anti-1, 2-nitroalkanol compoundMICROBIAL CHEM RES FOUND·Filed 2016·Granted Sep 17, 2019·0 cites·10 claims
- 0549US2019315734A1Purification method for 5-(thiazol-4-yl)indolin-2-one derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 0648US2022380348A1Axl inhibitor formulationsSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 0743US10377749B2Purification method for 5-(thiazol-4-yl)indolin-2-one derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Aug 13, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Akihito Nonoyama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →